Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy
Hanna A. Knaus, Sofia Berglund, Hubert Hackl, et al.
JCI Insight (2018) Vol. 3, Iss. 21
Open Access | Times Cited: 171

Showing 26-50 of 171 citing articles:

Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
Pier Edoardo Rovatti, Valentina Gambacorta, Francesca Lorentino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 50
CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to Success
Salvatore Fiorenza, Cameron J. Turtle
BioDrugs (2021) Vol. 35, Iss. 3, pp. 281-302
Closed Access | Times Cited: 45
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N. Desai, Bofei Wang, André Fonseca, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 1011-1028
Open Access | Times Cited: 17
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial
Shiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
Krzysztof Giannopoulos
Journal of Clinical Medicine (2019) Vol. 8, Iss. 2, pp. 236-236
Open Access | Times Cited: 54
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
Anusha Pusuluri, Debra Wu, Samir Mitragotri
Journal of Controlled Release (2019) Vol. 305, pp. 130-154
Closed Access | Times Cited: 51
OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers
Yayi He, Xiaoshen Zhang, Keyi Jia, et al.
Translational Lung Cancer Research (2019) Vol. 8, Iss. 4, pp. 352-366
Open Access | Times Cited: 45
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
Stephanie Sendker, Dirk Reinhardt, Naghmeh Niktoreh
Cancers (2021) Vol. 13, Iss. 6, pp. 1423-1423
Open Access | Times Cited: 38
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
Francesca Ferraro, Christopher A. Miller, Keegan A. Christensen, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 49
Open Access | Times Cited: 36
p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells
Valérie Janelle, Mathieu Neault, Marie‐Ève Lebel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow
Ling Xu, Lian Liu, Danlin Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways
Khalid Otmani, Rédouane Rouas, Laurence Lagneaux, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
Beatriz Guijarro-Albaladejo, Cristina Marrero-Cepeda, Eduardo Rodríguez‐Arbolí, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
Xiao‐Dong Mo, Weilong Zhang, Guomei Fu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2309-2322
Closed Access | Times Cited: 5
The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis
Cancers (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access
Acute myeloid leukaemia and the immune system: implications for immunotherapy
A. John Barrett
British Journal of Haematology (2019) Vol. 188, Iss. 1, pp. 147-158
Open Access | Times Cited: 38
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Kah Keng Wong, Rosline Hassan, Nik Soriani Yaacob
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
Russell Towers, Lidia Trombello, Maximilian Fusenig, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 1
Open Access | Times Cited: 4
Senescent T Cells in Age-Related Diseases
Pei-Jie Yu, Mei Zhou, Yan Liu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Integrated Computational Analysis Reveals Early Genetic and Epigenetic AML Susceptibility Biomarkers in Benzene-Exposed Workers
Silvia Vivarelli, Çiğdem Sevim, Federica Giambò, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1138-1138
Open Access
A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia
Yaoyao Wang, Xiancong Yang, Yalin Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Battlegrounds of treatment resistance: decoding the tumor microenvironment
Mobina Bayat, Javid Sadri Nahand
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia
Mingying Li, Tao Sun, Mengyuan Chang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways
Jan Philipp Bewersdorf, Rory M. Shallis, Amer M. Zeidan
Blood Reviews (2020) Vol. 45, pp. 100709-100709
Closed Access | Times Cited: 32
The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
Fang Hao, Christine Sholy, Chen Wang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3376-3376
Open Access | Times Cited: 25

Scroll to top